In a first controlled human study, oral methylone (50–200 mg) showed rapid, dose‑proportional (linear) pharmacokinetics with Cmax and AUC increasing proportionally, Tmax ≈1.5–2 h and t1/2 ≈6–7 h. A validated LC–MS/MS assay quantified methylone, MDMA and metabolites and found the primary metabolite HMMC had much lower exposure (Cmax ~10–14× and AUC ~21–29× lower) and faster kinetics than the parent drug.
- Published
- Journal
- International Journal of Molecular Sciences
- Authors
- Poyatos, L., Lo Faro, A., Sprega, G., Malaca, S., Pichini, S., Huestis, M. A., Papaseit, E., Busardo, F., Farré, M., Beradinelli, D., Perez-Castillo, A.